Medco Contracts Will Minimize Impact Of Pricing Changes, PBM Says
Executive Summary
Medco believes the structure of its contracts will shield the company from any fallout from changes to drug benchmark prices brought on by a proposed legal settlement by drug price publisher First DataBank
You may also be interested in...
Express Scripts Aims To Mitigate AWP Settlement Impact, CEO Paz Says
Express Scripts' review of the First DataBank suit on average wholesale price mark-ups suggests that its major challenge will be managing client expectations about the impact of the suit's proposed settlement
Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
MADIT-CRT Data Support Expanded Cardiac Resynchronization Market
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.